The global hepatitis B diagnostic tests market is on the cusp of substantial expansion, driven by a combination of increasing disease incidence, heightened global awareness campaigns, and rapid ...
Research analyzing European survey data from 113,884 men who have sex with men (MSM) and published in Eurosurveillance ...
Tune Therapeutics Moves into Clinical Spotlight with TUNE-401: A First-in-Class Epigenetic Silencer for Hepatitis B ...
Chronic viral hepatitis is the long-term inflammation of the liver. It is caused by hepatitis B, C or D virus particles. Even ...
Axios Vitals on MSN1d
Seattle firm targets hepatitis B through gene-editingA Seattle biotech company is working on a tweak to gene expression that could shut down hepatitis B (HBV), one of the viruses ...
New Zealand approved Tune Therapeutics' TUNE-401, an epigenetic editing therapy for chronic hepatitis B, for human trials.
A new study conducted by the Hepatitis Research Group at the Medical Research Council Unit The Gambia at the London School of ...
Research analysing European survey data from 113,884 men who have sex with men (MSM) and published in Eurosurveillance ...
Strong public health support and creating an open environment that enables MSM to follow recommendations will be crucial to ...
Dr . Kafui Senya, the Technical Lead for Hepatitis at the World Health Organization (WHO) country office, has stated that ...
Research analysing European survey data from 113,884 men who have sex with men (MSM) and published in Eurosurveillance indicates that while most MSM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback